There's been lots of MIS-UNDERSTOOD press about Rezulin (troglitazone) going off the market

There's been lots of MIS-UNDERSTOOD press about Rezulin(troglitazone) going off the market.

It was taken off the market in England last year.

It was eliminated from the big NIH Diabetes PREVENTION Study.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote